American biotechnology company in Massachusetts working on small molecules for neurodegenerative disease. Targets the stress granule biology that underlies the abnormal accumulation of RNA binding proteins such as TDP-43 in amyotrophic lateral sclerosis and frontotemporal dementia, runs its own discovery chemistry and cell based screening, and works with academic founders and partners on preclinical development.
コメントはありません。
評価とコメントを残す